Both in Pharmaceuticals
IDEAYA Biosciences vs Enliven Therapeutics
Over the past year IDYA returned −1.0% and ELVN returned +96.9%; their daily moves had a correlation of 0.12.
IDYA −1.0% ELVN +96.9%Growth of $1, one year, split-adjusted
| Metric | IDYA | ELVN |
|---|---|---|
| Price | $31.86 | $44.60 |
| Market cap | $3.07B | $3.27B |
| Today | −3.15% | −1.06% |
| 1 month | −15.7% | −3.5% |
| 6 months | +13.0% | +7.0% |
| Year to date | −7.9% | +189.6% |
| 1 year | −1.0% | +96.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −1269.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 13.1× | — |
| Net cash | $829.0M | $895.2M |
| Dividend yield | — | — |
| Volatility (60d) | 37.4% | 40.0% |
| Short % of float | 10.4% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).